KIWA BIO-TECH PRODUCTS GROUP CORP: 10-Q/A filed 2012-08-29
What KIWA BIO-TECH PRODUCTS GROUP CORP reported in its quarterly report amendment filed 2012-08-29 (fiscal Q2 2012): 25 published measures, 72 facts as tagged in accession 0001144204-12-048496.
This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.
This filing
- Form
- 10-Q/A (quarterly report amendment)
- Filed
- 2012-08-29
- Fiscal period
- fiscal Q2 2012
- Accession
- 0001144204-12-048496 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All KIWA BIO-TECH PRODUCTS GROUP CORP filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 48,581 | USD | |
| At 2011-12-31 | 62,999 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 13,073,245 | USD | |
| At 2011-12-31 | 12,408,437 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | -13,024,664 | USD | |
| At 2011-12-31 | -12,345,438 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 4,268 | USD | |
| At 2011-12-31 | 16,307 | USD | |
| At 2011-06-30 | 18,024 | USD | |
| At 2010-12-31 | 32,816 | USD |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | -162,509 | USD | 182 |
| 2011-01-01 to 2011-06-30 | -348,930 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 146,951 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 428,243 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | -21,057,712 | USD | |
| At 2011-12-31 | -20,362,032 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 0 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 0 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 0 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 0 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | -283,161 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -569,356 | USD | 182 |
| 2011-04-01 to 2011-06-30 | -375,018 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -789,765 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 30,756 | USD | |
| At 2011-12-31 | 42,677 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 63,164 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 126,324 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 78,226 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 140,179 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 11,263,076 | USD | |
| At 2011-12-31 | 10,593,526 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 283,161 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 569,356 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 375,018 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 789,765 | USD | 181 |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 0 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 0 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 0 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 0 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 39,491 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 79,254 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 40,317 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 78,284 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 400,000,000 | shares | |
| At 2011-12-31 | 400,000,000 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | -460,289 | USD | |
| At 2011-12-31 | -476,743 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 17,825 | USD | |
| At 2011-12-31 | 20,322 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | -346,325 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -695,680 | USD | 182 |
| 2011-04-01 to 2011-06-30 | -453,244 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -929,944 | USD | 181 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | -346,325 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -695,680 | USD | 182 |
| 2011-04-01 to 2011-06-30 | -453,244 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -929,944 | USD | 181 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | -288,194 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -679,226 | USD | 182 |
| 2011-04-01 to 2011-06-30 | -537,180 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -1,073,130 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 243,670 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 490,102 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 334,701 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 711,481 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 2,454 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 3,640 | USD | 181 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 0 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 0 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 0 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 17,406 | USD | 181 |
Inspect the source
- Entity
- KIWA BIO-TECH PRODUCTS GROUP CORP / CIK 0001159275
- Captured
- SEC response SHA-256
074c7ef0a833d858f3545ca8e68cbd9838b9689e73d55bfdb4b8ce50c68f0c88
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001159275.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))